AbCellera Biologics' Unattributed - II Round

AbCellera Biologics raised a round of funding on March 19, 2018.

AbCellera Biologics is a privately held company that provides technologies to biotechnology and pharmaceutical partners with the goal of discovery and development of next-generation monoclonal antibod…

Articles about AbCellera Biologics' Unattributed - II Round: